Podcasts
The Heart of Prevention
Enjoy ASPC's newly launched podcast "The Heart of Prevention" available on Apple, Spotify, and Amazon.
ASPC also partners with the CardioNerds on a variety of prevention-related topics. Below is a list of all of the episodes currently available.
ATTR-CM Series
This newly launched series provides a comprehensive overview of transthyretin (ATTR) cardiac amyloidosis, a complex and rapidly evolving disease process. The discussion cover the key red flags for cardiac amyloidosis, the diagnostic pathway, and the implications of hereditary versus wild-type ATTR. Importantly, the episodes delve into the current and emerging therapies for ATTR, including stabilizers, gene silencers, and promising treatments like CRISPR-Cas9 and antibody-based approaches.
ATTR-CM: The Biology of Transthyretin Amyloid Cardiomyopathy
Cardio-Rheumatology Series
The CardioNerds Cardiovascular Prevention Series has delved into the world of inflammation and its role in Cardiovascular Disease. Inflammation is involved both in the pathogenesis and progression of atherosclerosis. Inflammation may be the inciting factor in atherosclerosis, or it may amplify the process driven primarily by other risk factors. Therefore, treating the comorbidities and traditional CVD contributors is key to reducing the vicious inflammatory cycle. This series will take us through it all! It is supported by and unrestricted educational sponsorship from Agepha Pharma. All CardioNerds content is planned, produced, and reviewed solely by CardioNerds.
Cardio-Rheumatology: The Role of Inflammation in Cardiovascular Disease with Dr. Antonio Abbate
Cardio-Rheumatology: Targeting Inflammation for Cardiovascular Risk Reduction with Dr. Paul Ridker
SGLT Inhibition Series
The CardioNerds Cardiovascular Prevention Series brings us into the world of SGLT inhibitors. Initially developed as antidiabetic medications, SGLT inhibitors have been shown to have beneficial effects on cardiovascular and renal outcomes. These benefits result from their on-target glucosuric effects and additional off-target effects. This series will guide us through a comprehensive mechanism for Cardiovascular Disease (CVD) prevention and heart failure management, supported by unrestricted educational sponsorship from Lexicon. All CardioNerds content is planned, produced, and reviewed solely by CardioNerds.
SGLT Inhibitors: The Biology of SGLT Inhibition with Dr. Katherine Tuttle
SGLT Inhibitors: The Data Supporting SGLT Inhibition with Dr. Muthiah Vaduganathan
SGLT Inhibitors: Clinical Implementation of SGLT Inhibitors with Dr. Alison Bailey
Obesity and GLP-1 RAs
The CardioNerds Cardiovascular Prevention Series dives into Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs). This class of medications is becoming a household name, not only for their implications for weight loss but also for their effect on cardiovascular disease. This series also highlights the impact of obesity on cardiovascular disease risk, differential risk in specific populations, and effective strategies for counseling patients. This series is supported by unrestricted educational sponsorship from Novo Nordisk. All CardioNerds content is planned, produced, and reviewed solely by CardioNerds.
GLP-1 Agonists: Mechanisms to Applications with Dr. Dennis Bruemmer
Obesity: Obesity & Cardiovascular Disease Risk with Dr. Jaime Almandoz
Obesity: Lifestyle & Pharmacologic Management of Obesity with Dr. Ambarish Pandey
GLP-1 Agonists: Diving into the Data with Dr. Darren McGuire
GLP-1 Agonists: Clinical Implementation of GLP-1 Receptor Agonists with Dr. Neha Pagidapati
Obesity: Procedural Management of Obesity with Dr. Steve Nissen
Cardiovascular Genomics
The CardioNerds Cardiovascular Genomics series is a multi-institutional collaboration made possible by contributions of stellar fellow leads and expert faculty from several programs. The field of Cardiovascular Genomics has advanced significantly over the past two decades, having a profound clinical impact and altering the perception of the role and scope of genetic testing in various cardiovascular domains. This series is supported by unrestricted educational sponsorship from Illumina, Inc. All CardioNerds content is planned, produced, and reviewed solely by CardioNerds.
Lipid Series
The CardioNerds Lipid Series is a comprehensive series led by series co-chairs Dr. Rick Ferraro, cardiology fellow at The Johns Hopkins Hospital, and Dr. Tommy Das, cardiology fellow at The Cleveland Clinic, and produced in collaboration with the American Society for Preventive Cardiology (ASPC). This series has been made possible by unrestricted support from Amgen and Amarin.
131. Lipids: LDL Physiology & Function with Dr. Peter Toth
139. Lipids: LDL, Cardiovascular Events, & Disparities in Care with Dr. Keith Ferdinand
143. Lipids: (Non)-Fasting LDL & Furious Lipid Lowering with Dr. Alison Bailey
156. Lipids: Triglycerides – Pathophysiology to Clinical Outcomes with Dr. Matthew Budoff
161. Triglycerides - Deep Dive into EPA and DHA with Dr. Erin Michos
194. Lipids: Omega-3 Fatty Acids & The Battle Of The Oils with Dr. Pam Taub
207. Lipids: REDUCE-IT Versus STRENGTH Trials – EPA in Clinical Practice with Dr. Peter Toth
214. Lipids: Review of Icosapent Ethyl with Dr. Michael Shapiro